Cranial ganglion development

pathway activity — cross-omics
GO:0061550Cross-omicsRNA → PROTEIN-MSPatientPairwise association · TCGA cohorts

Across TCGA patient cohorts, RNA activity of the Cranial ganglion development pathway is significantly associated with the protein abundance of multiple proteins, with the LSCC cohort showing a particularly strong set of associations.

The most reproducible pathway-associated proteins across cancer lineages are PGM2L1, ALYREF, and HNRNPA2B1, each associated with the pathway in up to 7 cancer types. Since the analysis shows associations rather than directional relationships, both pathway-to-partner and partner-to-pathway views are reported.

Each partner is linked to its corresponding Q-omics profile. The scatter plot shows the strongest association, Cranial ganglion development activity versus PGM2L1 in LSCC (Pearson r = 0.48).

Pathway-associated proteins by consensus

Ranked by combined sampling and lineage consensus. X-score (pathway→partner) and Y-score (partner→pathway) are standardized regression coefficients; both directions are reported because the association is undirected. The reported p-values are derived from the association test.
LineagePartner proteinX-scoreY-scorep(X)p(Y)Sampling consensusLineage consensus
LSCCPGM2L1 →+0.706+0.116<.001<.00137
GBMALYREF →-0.378-0.176<.001<.00136
OVHNRNPA2B1 →-0.224-0.061<.001.00436
GBMSF3B2 →-0.256-0.126<.001.00236
OVZKSCAN8_S193 →-0.838-0.069.001.00236
GBMFUS →-0.430-0.156<.001<.00136
Each partner links to its Q-omics profile. Showing the 6 strongest associations by consensus.

GO:0061550 vs PGM2L1 — LSCC

Per-sample scatter of Cranial ganglion development activity vs PGM2L1 in LSCC.

Explore this scatter interactively →

Exploration